Perindopril alleviates inflammation via Cyclooxygenase inhibition: a bioinformatics, in vitro and in vivo evaluation

Background and Objective: Perindopril (PER), an angiotensin-converting enzyme (ACE) inhibitor with anti-apoptotic, antioxidant and anti-inflammatory characteristics, has long been used to treat cardiovascular illnesses. In this study, the enzyme inhibitory activity of PER against Cyclooxygenase-1 (C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: El Sebaei, Mahmoud (VerfasserIn) , Zabady, Mohamed Karam (VerfasserIn) , Ghonim, Ibrahim (VerfasserIn) , Hereba, Abdulrahman Taha (VerfasserIn) , Abdelghany, Ahmed Meligy (VerfasserIn) , El-Bahr, Sabry Mohamed (VerfasserIn) , Gaballa, Mohamed Mahmoud Salem Ahmed (VerfasserIn) , Kandeel, Mahmoud (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2023
In: International journal of pharmacology
Year: 2023, Jahrgang: 19, Heft: 3, Pages: 428-438
ISSN:1812-5700
DOI:10.3923/ijp.2023.428.438
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3923/ijp.2023.428.438
Verlag, kostenfrei, Volltext: https://www.scialert.net/abstract/?doi=ijp.2023.428.438
Volltext
Verfasserangaben:Mahmoud El Sebaei, Mohamed Karam Zabady, Ibrahim Ghonim, Abdulrahman Taha Hereba, Ahmed Meligy Abdelghany, Sabry Mohamed El-Bahr, Mohamed Mahmoud Salem Gaballa and Mahmoud Kandeel

MARC

LEADER 00000caa a2200000 c 4500
001 1902192249
003 DE-627
005 20241205171116.0
007 cr uuu---uuuuu
008 240909s2023 xx |||||o 00| ||eng c
024 7 |a 10.3923/ijp.2023.428.438  |2 doi 
035 |a (DE-627)1902192249 
035 |a (DE-599)KXP1902192249 
035 |a (OCoLC)1475311237 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 53  |2 sdnb 
100 1 |a El Sebaei, Mahmoud  |d 1980-  |e VerfasserIn  |0 (DE-588)1341437140  |0 (DE-627)190219280X  |4 aut 
245 1 0 |a Perindopril alleviates inflammation via Cyclooxygenase inhibition  |b a bioinformatics, in vitro and in vivo evaluation  |c Mahmoud El Sebaei, Mohamed Karam Zabady, Ibrahim Ghonim, Abdulrahman Taha Hereba, Ahmed Meligy Abdelghany, Sabry Mohamed El-Bahr, Mohamed Mahmoud Salem Gaballa and Mahmoud Kandeel 
264 1 |c 2023 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.09.2024 
520 |a Background and Objective: Perindopril (PER), an angiotensin-converting enzyme (ACE) inhibitor with anti-apoptotic, antioxidant and anti-inflammatory characteristics, has long been used to treat cardiovascular illnesses. In this study, the enzyme inhibitory activity of PER against Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) was determined. Materials and Methods: The PERʼs anti-inflammatory actions were estimated by in vitro COX-1 and COX-2 inhibition assays, the in vivo rat model of carrageenan-induced paw edema, histopathological examination, molecular modeling, docking and molecular dynamics studies. The data were analyzed using the Analysis of Variance (ANOVA) Test. Results: The PER IC50 values for COX-1 and COX-2 were calculated to be 8.3 and 0.1 µM, respectively, showing that PER has an 85.5-fold higher affinity for COX-2 than for COX-1. The PER was found to be a moderate inflammation suppressor in rat paw assay, comparable to celecoxib and indomethacin. Docking and molecular dynamics (MD) simulation supported the stable binding of PER with COX-2. Conclusion: Current findings revealed that PER can be used for local acute inflammation and utilized as a substitute for other topical anti-inflammatory medicines, particularly those containing steroids. 
700 1 |a Zabady, Mohamed Karam  |e VerfasserIn  |4 aut 
700 1 |a Ghonim, Ibrahim  |e VerfasserIn  |4 aut 
700 1 |a Hereba, Abdulrahman Taha  |e VerfasserIn  |4 aut 
700 1 |a Abdelghany, Ahmed Meligy  |e VerfasserIn  |4 aut 
700 1 |a El-Bahr, Sabry Mohamed  |e VerfasserIn  |4 aut 
700 1 |a Gaballa, Mohamed Mahmoud Salem Ahmed  |e VerfasserIn  |0 (DE-588)1200221656  |0 (DE-627)1682501132  |4 aut 
700 1 |a Kandeel, Mahmoud  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of pharmacology  |d Faisalābād : Asian Network for Scientific Information, 2005  |g 19(2023), 3, Seite 428-438  |h Online-Ressource  |w (DE-627)479468125  |w (DE-600)2177288-5  |w (DE-576)34727045X  |x 1812-5700  |7 nnas  |a Perindopril alleviates inflammation via Cyclooxygenase inhibition a bioinformatics, in vitro and in vivo evaluation 
773 1 8 |g volume:19  |g year:2023  |g number:3  |g pages:428-438  |g extent:12  |a Perindopril alleviates inflammation via Cyclooxygenase inhibition a bioinformatics, in vitro and in vivo evaluation 
856 4 0 |u https://doi.org/10.3923/ijp.2023.428.438  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.scialert.net/abstract/?doi=ijp.2023.428.438  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240909 
993 |a Article 
994 |a 2023 
998 |g 1200221656  |a Gaballa, Mohamed Mahmoud Salem Ahmed  |m 1200221656:Gaballa, Mohamed Mahmoud Salem Ahmed  |p 7 
999 |a KXP-PPN1902192249  |e 4578202232 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Perindopril alleviates inflammation via Cyclooxygenase inhibition","title":"Perindopril alleviates inflammation via Cyclooxygenase inhibition","subtitle":"a bioinformatics, in vitro and in vivo evaluation"}],"person":[{"family":"El Sebaei","given":"Mahmoud","display":"El Sebaei, Mahmoud","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Zabady, Mohamed Karam","given":"Mohamed Karam","family":"Zabady"},{"given":"Ibrahim","family":"Ghonim","role":"aut","display":"Ghonim, Ibrahim","roleDisplay":"VerfasserIn"},{"given":"Abdulrahman Taha","family":"Hereba","role":"aut","roleDisplay":"VerfasserIn","display":"Hereba, Abdulrahman Taha"},{"display":"Abdelghany, Ahmed Meligy","roleDisplay":"VerfasserIn","role":"aut","family":"Abdelghany","given":"Ahmed Meligy"},{"display":"El-Bahr, Sabry Mohamed","roleDisplay":"VerfasserIn","role":"aut","family":"El-Bahr","given":"Sabry Mohamed"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Gaballa, Mohamed Mahmoud Salem Ahmed","given":"Mohamed Mahmoud Salem Ahmed","family":"Gaballa"},{"given":"Mahmoud","family":"Kandeel","role":"aut","display":"Kandeel, Mahmoud","roleDisplay":"VerfasserIn"}],"note":["Gesehen am 09.09.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1902192249","origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"id":{"doi":["10.3923/ijp.2023.428.438"],"eki":["1902192249"]},"name":{"displayForm":["Mahmoud El Sebaei, Mohamed Karam Zabady, Ibrahim Ghonim, Abdulrahman Taha Hereba, Ahmed Meligy Abdelghany, Sabry Mohamed El-Bahr, Mohamed Mahmoud Salem Gaballa and Mahmoud Kandeel"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"title":[{"title":"International journal of pharmacology","subtitle":"IJP","title_sort":"International journal of pharmacology"}],"origin":[{"publisherPlace":"Faisalābād","dateIssuedDisp":"2005-","dateIssuedKey":"2005","publisher":"Asian Network for Scientific Information"}],"id":{"issn":["1812-5700"],"eki":["479468125"],"zdb":["2177288-5"]},"disp":"Perindopril alleviates inflammation via Cyclooxygenase inhibition a bioinformatics, in vitro and in vivo evaluationInternational journal of pharmacology","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"479468125","language":["eng"],"pubHistory":["1.2005 -"],"part":{"year":"2023","issue":"3","pages":"428-438","volume":"19","text":"19(2023), 3, Seite 428-438","extent":"12"}}]} 
SRT |a ELSEBAEIMAPERINDOPRI2023